Abatacept |
L04 |
Immunosuppressants |
0.4% |
✓ |
|
✓ |
Acamprosate |
N07 |
Other nervous system drugs |
<0.1% |
✓ |
|
|
Acarbose |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Acebutolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Acenocoumarol |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
Acetazolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Acetylcysteine |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
Acitretin |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
Aclidinium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Acyclovir |
J05 |
Antivirals for systemic use |
0.1% |
|
✓ |
|
Adalimumab |
L04 |
Immunosuppressants |
3.3% |
✓ |
|
✓ |
Adapalene |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
Adapalene, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
Adefovir dipivoxil |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
Alendronic acid |
M05 |
Drugs for treatment of bone diseases |
0.1% |
|
✓ |
|
Alendronic acid and cholecalciferol |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
Alfa-1 antitrypsin |
B02 |
Antihemorrhagics |
0.1% |
✓ |
|
✓ |
Alfuzosin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Alimemazine |
R06 |
Antihistamines for systemic use |
<0.1% |
✓ |
|
|
Aliskiren fumarate |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Alitretinoin |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
Allopurinol |
M04 |
Antigout preparations |
0.1% |
|
✓ |
|
Almotriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Alogliptin benzoate |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Alogliptin benzoate and metformin HCl |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Alprazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Alprostadil |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
Amantadine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Ambrisentan |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
Amcinonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Amfetamine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Amikacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Amiloride |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Amiodarone |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Amitriptyline |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
Amlodipine |
C08 |
Calcium channel blockers |
1.0% |
|
✓ |
|
Amoxicillin |
J01 |
Antibacterials for systemic use |
0.3% |
|
✓ |
|
Amoxicillin and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Amphotericin B |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
|
Ampicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Anakinra |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
✓ |
Anethole trithione |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
Antihypertensives for pulmonary arterial hypertension |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Antiinfectives, combinations |
S03 |
Ophthalmological and otological preparations |
<0.1% |
|
✓ |
|
Antispasmodics in combination with other drugs |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Apixaban |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
Apraclonidine |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Apremilast |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
Aprepitant |
A04 |
Antiemetics and antinauseants |
<0.1% |
✓ |
|
|
Aripiprazole |
N05 |
Psycholeptics |
0.8% |
✓ |
|
|
Asanepine |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
Atenolol |
C07 |
Beta blocking agents |
0.2% |
|
✓ |
|
Atenolol and other diuretics |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Atomoxetine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Atorvastatin |
C10 |
Lipid modifying agents |
1.8% |
|
✓ |
|
Atorvastatin and amlodipine |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
Atovaquone |
P01 |
Antiprotozoals |
<0.1% |
✓ |
|
|
Atropine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Auranofin |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
✓ |
|
|
Azathioprine |
L04 |
Immunosuppressants |
<0.1% |
|
✓ |
|
Azelaic acid |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
Azilsartan medoxomil |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Azithromycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Aztreonam |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
✓ |
Bacitracin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Baclofen |
M03 |
Muscle relaxants |
0.1% |
|
✓ |
|
Beclometasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Beclomethasone |
R01 |
Nasal preparations |
<0.1% |
|
✓ |
|
Benazepril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Benzathine benzylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Benzatropine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Benzoyl peroxide |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
Benzylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Betahistine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Betaine |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
Betamethasone |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.1% |
|
✓ |
|
Betamethasone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Betamethasone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Betaxolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Bethanechol |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Bezafibrate |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
Bimatoprost |
S01 |
Ophthalmologicals |
0.4% |
✓ |
|
|
Bismuth preparations |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Bisoprolol |
C07 |
Beta blocking agents |
0.1% |
|
✓ |
|
Boceprevir |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
✓ |
Bosentan |
C02 |
Antihypertensives |
0.2% |
|
✓ |
|
Botulinum toxin |
M03 |
Muscle relaxants |
0.5% |
✓ |
|
|
Brimonidine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Brinzolamide |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Brinzolamide, combinations |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Bromazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Bromocriptine |
G02 |
Other gynecologicals |
<0.1% |
|
✓ |
|
Budesonide |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.2% |
|
✓ |
|
Bumetanide |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
Bupivacaine |
N01 |
Anesthetics |
<0.1% |
✓ |
|
|
Buprenorphine, combinations |
N07 |
Other nervous system drugs |
0.2% |
|
✓ |
|
Bupropion |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
Buserelin |
L02 |
Endocrine therapy |
<0.1% |
✓ |
|
|
Buspirone |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Butorphanol |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Butylscopolamine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Cabergoline |
G02 |
Other gynecologicals |
<0.1% |
|
✓ |
|
Calcipotriol |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
Calcipotriol, combinations |
D05 |
Antipsoriatics |
0.2% |
✓ |
|
|
Calcitonin (salmon synthetic) |
H05 |
Calcium homeostasis |
<0.1% |
|
✓ |
|
Calcium folinate |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
Canagliflozin |
A10 |
Drugs used in diabetes |
0.1% |
✓ |
|
|
Candersartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Candesartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
Captopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Carbamazepine |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
Carvedilol |
C07 |
Beta blocking agents |
0.1% |
|
✓ |
|
Cefaclor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefadroxil |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefalexin |
J01 |
Antibacterials for systemic use |
0.2% |
|
✓ |
|
Cefazolin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefixime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefotaxime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefprozil |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Ceftazidime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Ceftriaxone |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Cefuroxime |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Celecoxib |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
Certolizumab pegol |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
Cetirizine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
Cetrorelix acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
Chloral hydrate |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Chloramphenicol |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Chlordiazepoxide |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Chloroquine |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
Chlorpromazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Chlorpropamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Chlortalidone |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Chlorzoxazone, combinations excluding psycholeptics |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
Choline theophyllinate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Ciclesonide |
R03 |
Drugs for obstructive airway diseases |
0.3% |
✓ |
|
|
Ciclopirox |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
Ciclosporin |
L04 |
Immunosuppressants |
0.2% |
|
✓ |
|
Cilazapril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Cilazapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Cimetidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
Cinacalcet |
H05 |
Calcium homeostasis |
<0.1% |
✓ |
|
|
Ciprofloxacin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Citalopram |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
Clarithromycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Clidinium and psycholeptics |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Clindamycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Clindamycin, combinations |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
Clobazam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Clobetasol |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Clobetasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
Clodronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
✓ |
|
|
Clomifene |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Clomipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Clonazepam |
N03 |
Antiepileptics |
0.1% |
|
✓ |
|
Clonidine |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Clopidogrel |
B01 |
Antithrombotic agents |
0.5% |
|
✓ |
|
Clorazepate potassium |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Clotrimazole |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
Cloxacillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Clozapine |
N05 |
Psycholeptics |
0.3% |
|
✓ |
|
Codeine, combinations with psycholeptics |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Codeine |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
Codeine, combinations excluding psycholeptics |
N02 |
Analgesics |
0.3% |
|
✓ |
|
Colchicine |
M04 |
Antigout preparations |
<0.1% |
|
✓ |
|
Colesevelam |
C10 |
Lipid modifying agents |
<0.1% |
✓ |
|
|
Colestipol |
C10 |
Lipid modifying agents |
<0.1% |
✓ |
|
|
Colestyramine |
C10 |
Lipid modifying agents |
0.1% |
|
✓ |
|
Colistin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Collagenase |
D03 |
Preparations for treatment of wounds and ulcers |
<0.1% |
✓ |
|
|
Conjugated estrogens |
G03 |
Sex hormones and modulators of the genital system |
0.1% |
|
✓ |
|
Cortisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
Cromoglicic acid |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Cyclobenzaprine |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
Cyclopentolate |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Cyproterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Cyproterone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Dabigatran etexilate |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
Dalteparin |
B01 |
Antithrombotic agents |
0.6% |
✓ |
|
|
Danazol |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Dantrolene |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
Dapagliflozin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Dapsone |
J04 |
Antimycobacterials |
<0.1% |
|
✓ |
|
Daptomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Darifenacin |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
Dasabuvir, ombitasvir, paritaprevir and ritonavir |
J05 |
Antivirals for systemic use |
0.1% |
✓ |
|
✓ |
Deferasirox |
V03 |
All other therapeutic products |
0.2% |
✓ |
|
✓ |
Deferoxamine |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
Denosumab |
M05 |
Drugs for treatment of bone diseases |
0.6% |
✓ |
|
|
Desipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Desmopressin |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
|
✓ |
|
Desogestrel and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Desonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Desoximetasone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Dexamethasone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
Dexamethasone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Dexamfetamine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
Dexlansoprazole |
A02 |
Drugs for acid related disorders |
<0.1% |
✓ |
|
|
Diazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Diazoxide |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
Diclofenac |
M01 |
Antiinflammatory and antirheumatic products |
0.1% |
|
✓ |
|
Diclofenac, combinations |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
Dicycloverine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Dienogest |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Diflucortolone |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
Digoxin |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Dihydroergotamine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Diltiazem |
C08 |
Calcium channel blockers |
0.7% |
|
✓ |
|
Dimethyl fumarate |
N07 |
Other nervous system drugs |
0.5% |
✓ |
|
|
Dimethyl sulfoxide |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Diphenhydramine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
Diphenoxylate |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Dipyridamole |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
Disopyramide |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
Domperidone |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Donepezil |
N06 |
Psychoanaleptics |
0.4% |
|
✓ |
|
Dornase alfa (desoxyribonuclease) |
R05 |
Cough and cold preparations |
<0.1% |
✓ |
|
|
Dorzolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Doxazosin |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Doxepin |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Doxycycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Doxylamine, combinations |
R06 |
Antihistamines for systemic use |
0.1% |
✓ |
|
|
Dronedarone |
C01 |
Cardiac therapy |
<0.1% |
✓ |
|
|
Drospirenone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Duloxetine |
N06 |
Psychoanaleptics |
1.5% |
✓ |
|
|
Dutasteride |
G04 |
Urologicals |
0.2% |
|
✓ |
|
Eculizumab |
L04 |
Immunosuppressants |
0.3% |
✓ |
|
✓ |
Eletriptan |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Eltrombopag |
B02 |
Antihemorrhagics |
<0.1% |
✓ |
|
✓ |
Enalapril |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
Enalapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Enoxaparin |
B01 |
Antithrombotic agents |
0.2% |
|
✓ |
|
Entacapone |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Entecavir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
Epinephrine |
C01 |
Cardiac therapy |
0.2% |
|
✓ |
|
Eplerenone |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
Epoprostenol |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
✓ |
Eprosartan |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Eprosartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Ergoloid mesylates |
C04 |
Peripheral vasodilators |
<0.1% |
|
✓ |
|
Ergotamine, combinations excluding psycholeptics |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Ertapenem |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Erythromycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Erythromycin, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
Escitalopram |
N06 |
Psychoanaleptics |
0.4% |
|
✓ |
|
Eslicarbazepine |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Esomeprazole |
A02 |
Drugs for acid related disorders |
0.2% |
|
✓ |
|
Estradiol |
G03 |
Sex hormones and modulators of the genital system |
0.3% |
|
✓ |
|
Estrone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Etacrynic acid |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Etanercept |
L04 |
Immunosuppressants |
2.2% |
✓ |
|
✓ |
Ethosuximide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Etidronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
Etidronic acid and calcium, sequential |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
Etodolac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Etynodiol and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Ezetimibe |
C10 |
Lipid modifying agents |
0.3% |
|
✓ |
|
Famciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
Famotidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
Febuxostat |
M04 |
Antigout preparations |
<0.1% |
✓ |
|
|
Felodipine |
C08 |
Calcium channel blockers |
0.2% |
|
✓ |
|
Fenofibrate |
C10 |
Lipid modifying agents |
0.2% |
|
✓ |
|
Fenoterol and ipratropium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Fentanyl |
N01 |
Anesthetics |
0.4% |
|
✓ |
|
Fesoterodine |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
Fidaxomicin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Filgrastim |
L03 |
Immunostimulants |
0.7% |
✓ |
|
|
Finasteride |
G04 |
Urologicals |
0.1% |
|
✓ |
|
Fingolimod |
L04 |
Immunosuppressants |
0.3% |
✓ |
|
✓ |
Flecainide |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Fluconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
|
✓ |
|
Fludrocortisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
✓ |
|
|
Flumetasone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
Flumetasone and antiinfectives |
S02 |
Otologicals |
<0.1% |
✓ |
|
|
Flunarizine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Flunisolide |
R01 |
Nasal preparations |
<0.1% |
|
✓ |
|
Fluocinolone acetonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Fluocinonide |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Fluorometholone |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Fluoxetine |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
Flupentixol |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Fluphenazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Flurazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Flurbiprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Fluticasone |
R03 |
Drugs for obstructive airway diseases |
0.9% |
|
✓ |
|
Fluticasone furoate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Fluvastatin |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
Fluvoxamine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Follitropin alfa |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Follitropin beta |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Fondaparinux |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
Formoterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Formoterol and budesonide |
R03 |
Drugs for obstructive airway diseases |
1.1% |
✓ |
|
|
Formoterol and mometasone |
R03 |
Drugs for obstructive airway diseases |
0.1% |
✓ |
|
|
Fosfomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Fosinopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Framycetin |
D09 |
Medicated dressings |
<0.1% |
✓ |
|
|
Furosemide |
C03 |
Diuretics |
0.2% |
|
✓ |
|
Fusidic acid |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
0.1% |
|
✓ |
|
Gabapentin |
N03 |
Antiepileptics |
0.7% |
|
✓ |
|
Galantamine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
Ganciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
|
Ganirelix acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
Gatifloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Gemfibrozil |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
Gentamicin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Glatiramer acetate |
L03 |
Immunostimulants |
0.5% |
✓ |
|
✓ |
Glibenclamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Gliclazide |
A10 |
Drugs used in diabetes |
0.3% |
|
✓ |
|
Glimepiride |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Glucagon |
H04 |
Pancreatic hormones |
<0.1% |
✓ |
|
|
Glyceryl trinitrate |
C01 |
Cardiac therapy |
0.2% |
|
✓ |
|
Glycopyrronium |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Glycopyrronium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Golimumab |
L04 |
Immunosuppressants |
0.5% |
✓ |
|
✓ |
Gonadorelin acetate |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
Gonadotrophine chorionique |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Goserelin |
L02 |
Endocrine therapy |
0.3% |
✓ |
|
|
Granisetron |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
Griseofulvin |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
Guanfacine HCl |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
Haloperidol |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Heparin |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
Hexachlorophene |
D08 |
Antiseptics and disinfectants |
<0.1% |
✓ |
|
|
Homatropine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Hydralazine |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Hydrochlorothiazide |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Hydrochlorothiazide and potassium-sparing agents |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Hydrocodone |
R05 |
Cough and cold preparations |
<0.1% |
|
✓ |
|
Hydrocortisone |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.2% |
|
✓ |
|
Hydrocortisone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Hydrocortisone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Hydrocortisone, combinations |
C05 |
Vasoprotectives |
<0.1% |
|
✓ |
|
Hydromorphone |
N02 |
Analgesics |
1.2% |
|
✓ |
|
Hydroxychloroquine |
P01 |
Antiprotozoals |
0.1% |
|
✓ |
|
Hydroxyquinoline derivatives |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
Hydroxyzine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Ibuprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Imidazoles/triazoles in combination with corticosteroids |
D01 |
Antifungals for dermatological use |
<0.1% |
✓ |
|
|
Imipenem and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Imipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Imiquimod |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
Indacaterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Indacaterol and glycopyrronium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Indapamide |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Indometacin |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Infliximab |
L04 |
Immunosuppressants |
5.1% |
✓ |
|
✓ |
Insulin (human) |
A10 |
Drugs used in diabetes |
0.7% |
|
✓ |
|
Insulin (pork) |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Insulin aspart |
A10 |
Drugs used in diabetes |
0.7% |
✓ |
|
|
Insulin detemir |
A10 |
Drugs used in diabetes |
0.5% |
✓ |
|
|
Insulin glargine |
A10 |
Drugs used in diabetes |
1.8% |
✓ |
|
|
Insulin glulisine |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Insulin lispro |
A10 |
Drugs used in diabetes |
0.6% |
✓ |
|
|
Interferon alfa-2b |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
Interferon beta-1a |
L03 |
Immunostimulants |
0.6% |
✓ |
|
✓ |
Interferon beta-1b |
L03 |
Immunostimulants |
0.1% |
✓ |
|
✓ |
Ipratropium bromide |
R01 |
Nasal preparations |
0.2% |
|
✓ |
|
Irbesartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
Irbesartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Isosorbide dinitrate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Isosorbide mononitrate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Isotretinoin |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
Itraconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
|
Ivacaftor |
R07 |
Other respiratory system products |
0.2% |
✓ |
|
✓ |
Ketoconazole |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
Ketoprofen |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Ketorolac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Ketotifen |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
Labetalol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Lacosamide |
N03 |
Antiepileptics |
0.1% |
✓ |
|
|
Lactic acid producing organisms |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Lamivudine |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
Lamotrigine |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
Lanreotide |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
✓ |
Lansoprazole |
A02 |
Drugs for acid related disorders |
0.4% |
|
✓ |
|
Lansoprazole, amoxicillin and clarithromycin |
A02 |
Drugs for acid related disorders |
<0.1% |
✓ |
|
|
Lanthanum carbonate |
V03 |
All other therapeutic products |
<0.1% |
✓ |
|
|
Latanoprost |
S01 |
Ophthalmologicals |
0.1% |
|
✓ |
|
Leflunomide |
L04 |
Immunosuppressants |
0.1% |
|
✓ |
|
Leuprorelin |
L02 |
Endocrine therapy |
0.5% |
✓ |
|
|
Levetiracetam |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
Levobunolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Levocarnitine |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
|
Levodopa and decarboxylase inhibitor |
N04 |
Anti-Parkinson drugs |
0.4% |
|
✓ |
|
Levodopa, decarboxylase inhibitor, and COMT inhibitor |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
Levofloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Levomepromazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Levonorgestrel and estrogen |
G03 |
Sex hormones and modulators of the genital system |
0.2% |
|
✓ |
|
Levothyroxine sodium |
H03 |
Thyroid therapy |
0.4% |
|
✓ |
|
Lidocaine |
D04 |
Antipruritics, incl. Antihistamines, anesthetics, etc. |
<0.1% |
|
✓ |
|
Linagliptin |
A10 |
Drugs used in diabetes |
0.4% |
✓ |
|
|
Lincomycin |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Linezolid |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Liothyronine sodium |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
Liraglutide |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Lisdexamfetamine |
N06 |
Psychoanaleptics |
0.2% |
✓ |
|
|
Lisinopril |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Lisinopril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Lithium |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Lodoxamide |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Loperamide |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Lorazepam |
N05 |
Psycholeptics |
0.1% |
|
✓ |
|
Losartan |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
Losartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Lovastatin |
C10 |
Lipid modifying agents |
<0.1% |
|
✓ |
|
Loxapine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Lurasidone |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
Macitentan |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
Mebendazole |
P02 |
Anthelmintics |
<0.1% |
✓ |
|
|
Medroxyprogesterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Mefenamic acid |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Mefloquine HCl |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
Megestrol |
L02 |
Endocrine therapy |
<0.1% |
|
✓ |
|
Meloxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Memantine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Meropenem |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Mesalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
0.6% |
|
✓ |
|
Mesuximide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Metformin |
A10 |
Drugs used in diabetes |
0.5% |
|
✓ |
|
Metformin and linagliptin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Metformin and rosiglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Metformin and saxagliptin |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Metformin and sitagliptin |
A10 |
Drugs used in diabetes |
1.0% |
✓ |
|
|
Methadone |
N07 |
Other nervous system drugs |
0.3% |
|
✓ |
|
Methazolamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Methenamine |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Methocarbamol, combinations excluding psycholeptics |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
Methoxalen, topical |
D05 |
Antipsoriatics |
<0.1% |
|
✓ |
|
Methyldopa (racemic) |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Methylphenidate |
N06 |
Psychoanaleptics |
0.5% |
|
✓ |
|
Methylprednisolone |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
Methylprednisolone, combinations |
H02 |
Corticosteroids for systemic use |
<0.1% |
✓ |
|
|
Metoclopramide |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Metolazone |
C03 |
Diuretics |
<0.1% |
✓ |
|
|
Metoprolol |
C07 |
Beta blocking agents |
0.3% |
|
✓ |
|
Metronidazole |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
Mexiletine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Miconazole |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
Midazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Midodrine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Milrinone lactate |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Minocycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Minoxidil |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
|
Mirtazapine |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
Misoprostol |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
Moclobemide |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Modafinil |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Mometasone |
D07 |
Corticosteroids, dermatological preparations |
0.2% |
|
✓ |
|
Montelukast |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Morphine |
N02 |
Analgesics |
0.4% |
|
✓ |
|
Moxifloxacin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Multienzymes (lipase, protease etc.) |
A09 |
Digestives, incl. Enzymes |
0.2% |
✓ |
|
|
Mycophenolic acid |
L04 |
Immunosuppressants |
0.3% |
|
✓ |
|
Nabilone |
A04 |
Antiemetics and antinauseants |
0.2% |
|
✓ |
|
Nabumetone |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Nadolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Nadroparin |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
Nafarelin |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
|
Naltrexone |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Naproxen |
M01 |
Antiinflammatory and antirheumatic products |
0.2% |
|
✓ |
|
Naratriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Natalizumab |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
Nateglinide |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Nedocromil |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Neomycin |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
Neostigmine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Nepafenac |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Nicotinic acid |
C04 |
Peripheral vasodilators |
<0.1% |
✓ |
|
|
Nifedipine |
C08 |
Calcium channel blockers |
0.9% |
|
✓ |
|
Nimodipine |
C08 |
Calcium channel blockers |
<0.1% |
✓ |
|
|
Nitrazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Nitrofurantoin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Nizatidine |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
Norelgestromin and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Norethisterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Norethisterone and estrogen |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Norfloxacin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Norgestimate and estrogen |
G03 |
Sex hormones and modulators of the genital system |
0.2% |
|
✓ |
|
Nortriptyline |
N06 |
Psychoanaleptics |
0.1% |
|
✓ |
|
Nystatin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Nystatin, combinations |
G01 |
Gynecological antiinfectives and antiseptics |
<0.1% |
✓ |
|
|
Ocriplasmin |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Octreotide |
H01 |
Pituitary and hypothalamic hormones and analogues |
0.5% |
|
✓ |
|
Ofloxacin |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Olanzapine |
N05 |
Psycholeptics |
0.5% |
|
✓ |
|
Olmesartan medoxomil |
C09 |
Agents acting on the renin-angiotensin system |
0.3% |
✓ |
|
|
Olmesartan medoxomil and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
✓ |
|
|
Olopatadine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Olsalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Omalizumab |
R03 |
Drugs for obstructive airway diseases |
0.2% |
✓ |
|
✓ |
Omeprazole |
A02 |
Drugs for acid related disorders |
0.5% |
|
✓ |
|
Ondansetron |
A04 |
Antiemetics and antinauseants |
0.2% |
|
✓ |
|
Opium |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Opium derivatives and expectorants |
R05 |
Cough and cold preparations |
<0.1% |
✓ |
|
|
Oral rehydration salt formulations |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Orciprenaline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Orlistat |
A08 |
Antiobesity preparations, excl. Diet products |
<0.1% |
✓ |
|
|
Orphenadrine (citrate) |
M03 |
Muscle relaxants |
<0.1% |
✓ |
|
|
Other aminoglycosides |
J01 |
Antibacterials for systemic use |
<0.1% |
✓ |
|
|
Other antiemetics |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
Oxazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Oxcarbazepine |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
Oxybutynin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Oxycodone |
N02 |
Analgesics |
0.5% |
|
✓ |
|
Oxycodone, combinations |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Paliperidone |
N05 |
Psycholeptics |
0.9% |
✓ |
|
|
Pamidronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
Pantoprazole |
A02 |
Drugs for acid related disorders |
1.9% |
|
✓ |
|
Papaverine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Paraldehyde |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Paromomycin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Paroxetine |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
Pegfilgrastim |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
✓ |
Peginterferon alfa-2a |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
Peginterferon alfa-2a, combinations |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
Peginterferon alfa-2b, combinations |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
|
Penicillamine |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Pentamidine isethionate |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
Pentazocine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Pentostan polysulfate sodium |
C05 |
Vasoprotectives |
<0.1% |
✓ |
|
|
Pentoxifylline |
C04 |
Peripheral vasodilators |
<0.1% |
|
✓ |
|
Perampanel |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Periciazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Perindopril |
C09 |
Agents acting on the renin-angiotensin system |
1.5% |
|
✓ |
|
Perindopril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.5% |
✓ |
|
|
Perphenazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Pethidine |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Phenelzine |
N06 |
Psychoanaleptics |
<0.1% |
✓ |
|
|
Phenobarbital |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
Phenoxymethylpenicillin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Phenylephrine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Phenytoin |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
Phosphodiesterase inhibitors |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Phytomenadione |
B02 |
Antihemorrhagics |
<0.1% |
|
✓ |
|
Pilocarpine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Pimecrolimus |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
Pimozide |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Pinaverium |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
✓ |
|
|
Pindolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Pindolol and other diuretics |
C07 |
Beta blocking agents |
<0.1% |
✓ |
|
|
Pioglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Piperacillin and enzyme inhibitor |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Pipotiazine |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
Piroxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Pizotifen |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Plastic IUD with progestogens |
G02 |
Other gynecologicals |
0.2% |
✓ |
|
|
Plerixafor |
L03 |
Immunostimulants |
<0.1% |
✓ |
|
✓ |
Podophyllotoxin |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
✓ |
|
|
Polystyrene sulphonate |
V03 |
All other therapeutic products |
<0.1% |
|
✓ |
|
Posaconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
✓ |
|
✓ |
Pramipexole |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Prasugrel |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
|
Pravastatin |
C10 |
Lipid modifying agents |
0.2% |
|
✓ |
|
Praziquantel |
P02 |
Anthelmintics |
<0.1% |
✓ |
|
|
Prazosin |
C02 |
Antihypertensives |
<0.1% |
|
✓ |
|
Prednisolone |
H02 |
Corticosteroids for systemic use |
0.1% |
|
✓ |
|
Prednisolone and antiinfectives |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Prednisone |
H02 |
Corticosteroids for systemic use |
<0.1% |
|
✓ |
|
Pregabalin |
N03 |
Antiepileptics |
0.3% |
|
✓ |
|
Primaquine |
P01 |
Antiprotozoals |
<0.1% |
✓ |
|
|
Primidone |
N03 |
Antiepileptics |
<0.1% |
|
✓ |
|
Probenecid |
M04 |
Antigout preparations |
<0.1% |
✓ |
|
|
Prochlorperazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Procyclidine |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Profenamine |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
Progesterone |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Promethazine |
R06 |
Antihistamines for systemic use |
<0.1% |
|
✓ |
|
Propafenone |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Propranolol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Propylthiouracil |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
Protease inhibitors |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
✓ |
Proxymetacaine |
S01 |
Ophthalmologicals |
<0.1% |
✓ |
|
|
Pyridostigmine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Quetiapine |
N05 |
Psycholeptics |
0.7% |
|
✓ |
|
Quinagolide |
G02 |
Other gynecologicals |
<0.1% |
✓ |
|
|
Quinapril |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
Quinapril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Quinidine |
C01 |
Cardiac therapy |
<0.1% |
|
✓ |
|
Quinine |
P01 |
Antiprotozoals |
<0.1% |
|
✓ |
|
Rabeprazole |
A02 |
Drugs for acid related disorders |
0.5% |
|
✓ |
|
Raloxifene |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
|
✓ |
|
Ramipril |
C09 |
Agents acting on the renin-angiotensin system |
0.7% |
|
✓ |
|
Ramipril and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Ranitidine |
A02 |
Drugs for acid related disorders |
0.3% |
|
✓ |
|
Rasagiline |
N04 |
Anti-Parkinson drugs |
<0.1% |
✓ |
|
|
Repaglinide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Ribavirin |
J05 |
Antivirals for systemic use |
<0.1% |
✓ |
|
|
Rifaximin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
✓ |
|
|
Riluzole |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Riociguat |
C02 |
Antihypertensives |
<0.1% |
✓ |
|
✓ |
Risedronic acid |
M05 |
Drugs for treatment of bone diseases |
0.7% |
|
✓ |
|
Risperidone |
N05 |
Psycholeptics |
0.7% |
|
✓ |
|
Rivaroxaban |
B01 |
Antithrombotic agents |
1.0% |
✓ |
|
|
Rivastigmine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Rizatriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Romiplostim |
B02 |
Antihemorrhagics |
<0.1% |
✓ |
|
✓ |
Ropinirole |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Rosiglitazone |
A10 |
Drugs used in diabetes |
<0.1% |
✓ |
|
|
Rosuvastatin |
C10 |
Lipid modifying agents |
1.3% |
|
✓ |
|
Rufinamide |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Salbutamol |
R03 |
Drugs for obstructive airway diseases |
0.4% |
|
✓ |
|
Salbutamol and ipratropium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Salmeterol |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Salmeterol and fluticasone |
R03 |
Drugs for obstructive airway diseases |
2.4% |
✓ |
|
|
Sapropterin |
A16 |
Other alimentary tract and metabolism products |
<0.1% |
✓ |
|
✓ |
Saxagliptin |
A10 |
Drugs used in diabetes |
0.3% |
✓ |
|
|
Scopolamine |
A04 |
Antiemetics and antinauseants |
<0.1% |
|
✓ |
|
Secukinumab |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
Selegiline |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Sertraline |
N06 |
Psychoanaleptics |
0.3% |
|
✓ |
|
Sevelamer |
V03 |
All other therapeutic products |
<0.1% |
✓ |
|
|
Sildenafil |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Silodosin |
G04 |
Urologicals |
0.2% |
✓ |
|
|
Silver sulfadiazine |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
<0.1% |
|
✓ |
|
Simvastatin |
C10 |
Lipid modifying agents |
0.4% |
|
✓ |
|
Sirolimus |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
Sitagliptin |
A10 |
Drugs used in diabetes |
1.3% |
✓ |
|
|
Sodium aurothiomalate |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Sodium tetradecyl sulphate |
C05 |
Vasoprotectives |
<0.1% |
|
✓ |
|
Sofosbuvir |
J05 |
Antivirals for systemic use |
1.3% |
✓ |
|
✓ |
Sofosbuvir and ledipasvir |
J05 |
Antivirals for systemic use |
5.2% |
✓ |
|
✓ |
Solifenacin |
G04 |
Urologicals |
0.2% |
|
✓ |
|
Somatropin |
H01 |
Pituitary and hypothalamic hormones and analogues |
0.2% |
✓ |
|
✓ |
Sotalol |
C07 |
Beta blocking agents |
<0.1% |
|
✓ |
|
Spiramycin |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Spironolactone |
C03 |
Diuretics |
<0.1% |
|
✓ |
|
Stiripentol |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Sucralfate |
A02 |
Drugs for acid related disorders |
<0.1% |
|
✓ |
|
Sufentanil |
N01 |
Anesthetics |
<0.1% |
|
✓ |
|
Sulfamethoxazole |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Sulfamethoxazole and trimethoprim |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Sulfasalazine |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Sulfinpyrazone |
M04 |
Antigout preparations |
<0.1% |
|
✓ |
|
Sulindac |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Sulphur, combinations |
D10 |
Anti-acne preparations |
<0.1% |
✓ |
|
|
Sumatriptan |
N02 |
Analgesics |
0.1% |
|
✓ |
|
Tacrolimus |
D11 |
Other dermatological preparations |
0.4% |
|
✓ |
|
Tamsulosin |
G04 |
Urologicals |
0.2% |
|
✓ |
|
Tazarotene |
D05 |
Antipsoriatics |
<0.1% |
✓ |
|
|
Telmisartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
Telmisartan and amlodipine |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Telmisartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
|
✓ |
|
Temazepam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Tenofovir disoproxil |
J05 |
Antivirals for systemic use |
0.5% |
✓ |
|
|
Tenoxicam |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Terazosin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Terbinafine |
D01 |
Antifungals for dermatological use |
<0.1% |
|
✓ |
|
Terbutaline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Terconazole |
G01 |
Gynecological antiinfectives and antiseptics |
<0.1% |
|
✓ |
|
Teriflunomide |
L04 |
Immunosuppressants |
0.1% |
✓ |
|
✓ |
Teriparatide |
H05 |
Calcium homeostasis |
<0.1% |
✓ |
|
|
Testosterone |
G03 |
Sex hormones and modulators of the genital system |
0.1% |
|
✓ |
|
Tetrabenazine |
N07 |
Other nervous system drugs |
<0.1% |
|
✓ |
|
Tetracosactide |
H01 |
Pituitary and hypothalamic hormones and analogues |
<0.1% |
✓ |
|
✓ |
Tetracycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Theophylline |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Theophylline, combinations excluding psycholeptics |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
|
✓ |
|
Thiamazole |
H03 |
Thyroid therapy |
<0.1% |
|
|
|
Thioridazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Thyroid gland preparations |
H03 |
Thyroid therapy |
<0.1% |
✓ |
|
|
Thyrotrophin |
V04 |
Diagnostic agents |
<0.1% |
✓ |
|
|
Tiaprofenic acid |
M01 |
Antiinflammatory and antirheumatic products |
<0.1% |
|
✓ |
|
Ticagrelor |
B01 |
Antithrombotic agents |
0.1% |
✓ |
|
|
Ticlopidine |
B01 |
Antithrombotic agents |
<0.1% |
|
✓ |
|
Tigecycline |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Timolol |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Timolol, combinations |
S01 |
Ophthalmologicals |
0.5% |
|
✓ |
|
Tinzaparin |
B01 |
Antithrombotic agents |
0.2% |
✓ |
|
|
Tiotixene |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
Tiotropium bromide |
R03 |
Drugs for obstructive airway diseases |
1.5% |
✓ |
|
|
Tizanidine |
M03 |
Muscle relaxants |
<0.1% |
|
✓ |
|
Tobramycin |
J01 |
Antibacterials for systemic use |
0.1% |
|
✓ |
|
Tocilizumab |
L04 |
Immunosuppressants |
0.2% |
✓ |
|
✓ |
Tofacitinib |
L04 |
Immunosuppressants |
<0.1% |
✓ |
|
|
Tolbutamide |
A10 |
Drugs used in diabetes |
<0.1% |
|
✓ |
|
Tolterodine |
G04 |
Urologicals |
0.3% |
|
✓ |
|
Topiramate |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
Trandolapril |
C09 |
Agents acting on the renin-angiotensin system |
0.3% |
✓ |
|
|
Trandolapril and verapamil HCl |
C09 |
Agents acting on the renin-angiotensin system |
<0.1% |
✓ |
|
|
Tranexamic acid |
B02 |
Antihemorrhagics |
<0.1% |
|
✓ |
|
Tranylcypromine |
N06 |
Psychoanaleptics |
<0.1% |
✓ |
|
|
Travoprost |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Trazodone |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Treprostinil |
B01 |
Antithrombotic agents |
<0.1% |
✓ |
|
✓ |
Tretinoin |
D10 |
Anti-acne preparations |
<0.1% |
|
✓ |
|
Triamcinolone |
A01 |
Stomatological preparations |
<0.1% |
|
✓ |
|
Triamcinolone and antibiotics |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
|
✓ |
|
Triazolam |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Trifluoperazine |
N05 |
Psycholeptics |
<0.1% |
|
✓ |
|
Trifluridine |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Trihexyphenidyl |
N04 |
Anti-Parkinson drugs |
<0.1% |
|
✓ |
|
Trimebutine |
A03 |
Drugs for functional gastrointestinal disorders |
<0.1% |
|
✓ |
|
Trimethoprim |
J01 |
Antibacterials for systemic use |
<0.1% |
|
✓ |
|
Trimipramine |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Triptorelin |
L02 |
Endocrine therapy |
<0.1% |
✓ |
|
|
Tropicamide |
S01 |
Ophthalmologicals |
<0.1% |
|
✓ |
|
Trospium |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
Tryptophan |
N06 |
Psychoanaleptics |
<0.1% |
|
✓ |
|
Ulipristal |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Ulobetasol |
D07 |
Corticosteroids, dermatological preparations |
<0.1% |
✓ |
|
|
Urinary antispasmodics |
G04 |
Urologicals |
<0.1% |
✓ |
|
|
Urinary concrement solvents |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Urofollitropin |
G03 |
Sex hormones and modulators of the genital system |
<0.1% |
✓ |
|
|
Ursodeoxycholic acid |
A05 |
Bile and liver therapy |
0.1% |
|
✓ |
|
Ustekinumab |
L04 |
Immunosuppressants |
0.5% |
✓ |
|
✓ |
Vaginal ring with progestogen and estrogen |
G02 |
Other gynecologicals |
<0.1% |
✓ |
|
|
Valaciclovir |
J05 |
Antivirals for systemic use |
0.5% |
|
✓ |
|
Valganciclovir |
J05 |
Antivirals for systemic use |
<0.1% |
|
✓ |
|
Valproic acid |
N03 |
Antiepileptics |
0.2% |
|
✓ |
|
Valsartan |
C09 |
Agents acting on the renin-angiotensin system |
0.2% |
|
✓ |
|
Valsartan and diuretics |
C09 |
Agents acting on the renin-angiotensin system |
0.1% |
|
✓ |
|
Vancomycin |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
<0.1% |
|
✓ |
|
Varenicline |
N07 |
Other nervous system drugs |
0.2% |
✓ |
|
|
Venlafaxine |
N06 |
Psychoanaleptics |
0.5% |
|
✓ |
|
Verapamil |
C08 |
Calcium channel blockers |
<0.1% |
|
✓ |
|
Vigabatrin |
N03 |
Antiepileptics |
<0.1% |
✓ |
|
|
Vilanterol and fluticasone furoate |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Vilanterol and umeclidinium bromide |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Voriconazole |
J02 |
Antimycotics for systemic use |
<0.1% |
|
✓ |
|
Warfarin |
B01 |
Antithrombotic agents |
0.2% |
|
✓ |
|
Wart and anti-corn preparations |
D11 |
Other dermatological preparations |
<0.1% |
✓ |
|
|
Yohimbin |
G04 |
Urologicals |
<0.1% |
|
✓ |
|
Zafirlukast |
R03 |
Drugs for obstructive airway diseases |
<0.1% |
✓ |
|
|
Ziprasidone |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|
Zoledronic acid |
M05 |
Drugs for treatment of bone diseases |
<0.1% |
|
✓ |
|
Zolmitriptan |
N02 |
Analgesics |
<0.1% |
|
✓ |
|
Zopiclone |
N05 |
Psycholeptics |
0.2% |
|
✓ |
|
Zuclopenthixol |
N05 |
Psycholeptics |
<0.1% |
✓ |
|
|